Abstract
Expression of the JCV early protein T-antigen in transgenic mice leads to the development of cerebellar primitive neuroectodermal tumors (PNETs). In light of earlier reports on the association of JCV with PNETs in humans and the involvement of the Wnt signaling pathway in the development of cerebellar tumors, we investigated the interplay between T-antigen and β-catenin, the key protein of the Wnt pathway. Our results demonstrate the physical interaction of T-antigen with β-catenin through the central domain of T-antigen spanning residues 82–628, and the C-terminus of β-catenin located between amino acids 695 and 781. The association of T-antigen with β-catenin elevates the level of β-catenin in the cells due to increased in the stability of the protein. In the presence of T-antigen, β-catenin was found in the nuclei of cells, suggesting that the interaction of β-catenin with T-antigen facilitates its nuclear import. In cells expressing mutant T-antigen with no nuclear localization domain, β-catenin was found in the cytoplasm. Coexpression of T-antigen with β-catenin increased the transcription of the c-myc promoter, a known downstream target of β-catenin, and artificial promoter whose activity is β-catenin dependent. These observations ascribe a new oncogenic pathway for T-antigen, and offer an alternative mechanism for the deregulation of the Wnt pathway through stabilization of β-catenin upon its association with the viral oncoprotein.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Agostini HT, Jobes DV and Stoner GL . (2001). Human Polyomaviruses: Molecular and Clinical Perspectives. Khalili K and Stoner GL (eds). Wiley-Liss: New York, NY, pp. 491–526.
Berger JR and Concha M . (1995). J. Neurovirol., 1, 5–18.
Berger JR and Major EO . (1999). Semin. Neurol., 19, 193–200.
Cadigan KM and Nusse R . (1997). Genes Dev., 11, 3286–3305.
Castano J, Raurell I, Piedra JA, Miravet S, Dunach M and de Harreros AG . (2002). J. Biol. Chem., 277, 31541–31550.
Del Valle L, Gordon J, Enam S, Delbue S, Croul S, Abraham S, Radhakrishnan S, Assimakoupoulou M, Katsetos CD and Khalili K . (2001b). J. Natl. Cancer Inst., 94, 267–273.
Del Valle L, Gordon J, Ferrante P and Khalili K . (2001a). Human Polyomaviruses: Molecular and Clinical Perspectives. Khalili K and Stoner GL (eds). Wiley-Liss: New York, NY, pp. 409–430.
Eberhart CG, Tihan T and Burger PC . (2000). J. Neuropathol. Exp. Neurol., 59, 333–337.
Fujimuro M, Wu FY, Aprhys C, Kajumbula H, Young DB, Hayward GS and Hayward D . (2003). Nat. Med., 9, 300–306.
Gallia GL, Gordon J and Khalili K . (1998). J. Neurovirol., 4, 175–181.
Gan DD, Reiss K, Carrill T, Del Valle L, Croul S, Giordano A, Fishman P and Khalili K . (2001). Oncogene, 20, 4864–4870.
Gao ZH, Seeling JM, Hill V, Yochum A and Virshup DM . (2002). Proc. Natl. Acad. Sci. USA, 99, 1182–1187.
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW . (1998). Science, 281, 1509–1512.
Hsu SC, Galceran J and Grosschedl R . (1998). Mol. Cell. Biol., 18, 4807–4818.
Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B and Clevers H . (1997). Science, 275, 1784–1787.
Krynska B, Del Valle L, Croul S, Gordon J, Katsetos CD, Carbone M, Giordano A and Khalili K . (1999a). Proc. Natl. Acad. Sci. USA, 96, 11519–11524.
Krynska B, Del Valle L, Gordon J, Otte J, Croul S and Khalili K . (2000). Virology, 274, 65–74.
Krynska B, Otte J, Franks R, Khalili K and Croul S . (1999b). Oncogene, 18, 39–46.
Morin PJ . (1999). Bioessays, 21, 1021–1030.
Polakis P . (2000). Genes Dev., 14, 1837–1851.
Polakis P . (2001). Cell, 105, 563–566.
Raj GV, Gordon J, Logan TJ, Hall DJ, De Luca A, Giordano A and Khalili K . (1995). Int. J. Oncol., 7, 801–808.
Safak M, Barrucco R, Darbinyan A, Okada Y, Nagashima K and Khalili K . (2001). J. Virol., 75, 1476–1486.
Shtutman M, Zhurinsky J, Simcha I, Albanese C, D’Amico M, Pestell R and Ben-Ze'ev A . (1999). Proc. Natl. Acad. Sci. USA, 96, 5522–5527.
Walker DL and Padgett BL . (1983). Polyomaviruses and Human Neurological Disease. Sever JL and Madden DM (eds). Alan R. Liss: New York, pp. 99–106.
Weiner HL, Bakst R, Hurlbert MS, Ruggiero J, Ahn E, Lee WS, Stephen D, Zagzag D, Joyner AL and Turnbull DH . (2002). Cancer Res., 62, 6385–6389.
Xu L, Corcoran RB, Welsh JW, Pennica D and Levine AJ . (2000). Genes Dev., 14, 585–595.
Acknowledgements
We thank the past and present members of the Center for Neurovirology and Cancer Biology, for their insightful discussion and sharing of reagents and ideas. We thank Drs François Fagotto, Rudolf Grosschedl, Ken WY Cho, Liliana Attisano, Bert Vogelstein, Frank McCormick, Dave Turner, Jacqueline Tanaka, and Ramin Shiekhattar for kindly providing plasmids which were used in these studies. We wish to express our gratitude to C Schriver for editorial assistance. This work was made possible by grants awarded by NIH to KK.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gan, DD., Khalili, K. Interaction between JCV large T-antigen and β-catenin. Oncogene 23, 483–490 (2004). https://doi.org/10.1038/sj.onc.1207018
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207018
Keywords
This article is cited by
-
Review on the role of the human Polyomavirus JC in the development of tumors
Infectious Agents and Cancer (2017)
-
JC polyomavirus in the aetiology and pathophysiology of glial tumours
Neurosurgical Review (2016)
-
Immune surveillance and response to JC virus infection and PML
Journal of NeuroVirology (2014)
-
Investigation of human JC and BK polyomaviruses in breast carcinomas
Breast Cancer Research and Treatment (2012)
-
A novel role of Rac1 GTPase in JCV T-antigen-mediated β-catenin stabilization
Oncogene (2007)